{
  "title": "Immune Responses to Influenza-Like Illness",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY406",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Immune Responses to Influenza-Like Illness",
  "performedBy": [
    {
      "firstName": "Harry",
      "lastName": "Greenberg",
      "email": "harry.greenberg@stanford.edu",
      "affiliations": [
          {
             "name": "Stanford School of Medicine"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "Influenza-Like Illness (ILI)",
          "size": 6
        }
  ],
  
  "usesReagent": [
        {
          "name": "PAXgene blood RNA tubes"
        },
        {
          "name": "PAXgene blood RNA kit"
        },
        {
          "name": "Bioanalyzer 600 NANO kit"
        },
        {
          "name": "GeneAtlas 3' IVT express kit"
        },
        {
          "name": "GeneAtlas hybridization, wash, and stain kit for 3?? IVT PrimeView assays"
        },
        {
          "name": "GeneChip PrimeView Human Gene Expression Array"
        },
        {
          "name": "Sodium Chloride"
        },
        {
          "name": "Chicken Red Blood Cells"
        },
        {
          "name": "Dulbecco's Phosphate Buffer Saline"
        },
        {
          "name": "Receptor Destroying Enzyme II"
        },
        {
          "name": "RosetteSep Human B Cell Enrichment Cocktail"
        },
        {
          "name": "FLUZONE  FLU VACCINE"
        },
        {
          "name": "Coating Solution Concentrate"
        },
        {
          "name": "Anti-Human IgG (gamma) Antibody, Peroxidase labeled"
        },
        {
          "name": "Anti-Human IgA (alpha) Antibody, Peroxidase labeled"
        },
        {
          "name": "TMB Microwell Peroxidase Substrate System"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "older than 18 years."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Meets the criteria for influenza-like illness (ILI) as defined by the CDC: fever (temperature of 100?F or greater) AND a cough and /or sore throat in the absence of known cause other than influenza."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Willing to complete the informed consent process."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Availability and willingness to complete an initial study visit with a brief follow-up phone call one week later. Completion of a second visit (approximately 28 days after visit 1) is encouraged, but optional."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Immunization with influenza vaccine within 14 days prior to the onset of flu-like symptoms."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "History of HIV, HBV or HCV infection"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Recent or current use of immunosuppressive medication, including systemic glucocorticoids (corticosteroid nasal sprays and topical steroids are permissible)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Receipt of blood or blood products within the past 6 months"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Donation of the equivalent of a unit of blood within 6 weeks prior to enrollment"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Pregnant woman"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Use of investigational agents within 30 days prior to enrollment"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Any condition which, in the opinion of the investigator, might interfere with volunteer safety, study objectives or the ability of the participant to understand or comply with the study protocol."
          ]
        }
  ],
  
  "types": [
      {
          "value": "Observational"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Harry",
      "lastName": "Greenberg",
      "email": "harry.greenberg@stanford.edu",
      "affiliations": [
          {
             "name": "Stanford School of Medicine"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Vaccination and infection: indicators of immunological health and responsiveness",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "AI090019"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "This U19 application focuses on three interrelated questions in human immunology, namely: (1) What distinguishes an effective from an ineffective immune response to a vaccine? (2) How do responses elicited by a vaccine against a particular pathogen differ from those associated witti actual infection and disease caused by the pathogen? (3) Given that a range of effective responses is likely to occur in response to a vaccine or infection, what does this variation tell us about key parameters of immunological health?  http://projectreporter.nih.gov/project_info_details.cfm?aid=8705360&icde=23811246&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Observational"
      },
      {
        "value": "Vaccine Response"
      }
  ],
  "dates": [
      {
          "date": "2013-02-24",
          "type": {
              "value": "actual_start_date"
          }
      },
      {
          "date": "2016-03-18",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Transcript Quantification"
        },
        "description": "affymetrix array",
        "types": [
            {
               "value": "Array"
            }
        ]
      },{
        "name": {
            "value": "Virus Titer"
        },
        "description": "None",
        "types": [
            {
               "value": "Hemagglutination Inhibition"
            }
        ]
      },{
        "name": {
            "value": "Molecular Quantification"
        },
        "description": "None",
        "types": [
            {
               "value": "ELISA"
            }
        ]
      }
      
  ],
  "isAbout": [
        {
          "name": "SLVP022_2013_Getreatment"
        },
        {
          "name": "SLVP022_2013_treatment"
        },
        {
          "name": "No treatment"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY406",
              "identifierSource": "ImmPort"
          },
          "title": "Immune Responses to Influenza-Like Illness",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY406",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Vaccination and infection: indicators of immunological health and responsiveness",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "http://projectreporter.nih.gov/project_info_details.cfm?aid=8527698&icde=23840268&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "To investigate the nasal transcriptional response and peripheral plasmablast response in acute influenza infection"
}
